Our state-of-the-art Vanrx® SA25 Aseptic Filling Workcell can be deployed to support your clinical or commercial drug product manufacturing needs. With a focus on product flexibility and preservation of your drug substance, watch our latest webinar to learn more and discover if the Vanrx is the right fit for your program.
Hear from Emergent technical experts and Vanrx (now part of Cytiva) representatives as they discuss the unique features of the Vanrx SA25 and the benefits of utilizing closed, robotic technologies to enhance aseptic filling operations.
This presentation will include:
- A brief introduction and history of Emergent's Winnipeg, Manitoba, Canada manufacturing facility
- An overview of the Vanrx SA25 Aseptic Filling Workcell design features and benefits
- Q&A session with Emergent's Winnipeg drug product manufacturing team and Vanrx representatives
MANUFACTURING NEXT-GEN THERAPIES: THE VANRX SA25 ASEPTIC FILLING WORKCELL
- Original Publish Date: June 23, 2021
Kevin Gadient - Director, Manufacturing Sciences & Technology, Winnipeg, Emergent
Aine Brennan - Microbiologist, Cytiva